| 摘要 |
The present invention relates to certain spirocyclic compounds that are inhibitors of 11-hydroxyl steroid dehydrogenase type 1 (11 HSD1), compositions containing the same, and methods of using the same for the treatment of diabetes, obesity and other diseases. |
